A Non-Interventional Long-term Safety Study of Ruxolitinib in Myelofibrosis

Trial Profile

A Non-Interventional Long-term Safety Study of Ruxolitinib in Myelofibrosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2016

At a glance

  • Drugs Ruxolitinib (Primary)
  • Indications Myelofibrosis
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
    • 11 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top